L
Luis M. Montuenga
Researcher at University of Navarra
Publications - 245
Citations - 10844
Luis M. Montuenga is an academic researcher from University of Navarra. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 48, co-authored 221 publications receiving 9205 citations. Previous affiliations of Luis M. Montuenga include Chartered Institute of Management Accountants & Carlos III Health Institute.
Papers
More filters
Journal ArticleDOI
Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (CEA) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles.
Lucia K Kiio,J. O. Onyatta,Peter M. Ndangili,Florence Oloo,Carolina Santamaria,Luis M. Montuenga,Damaris Mbui +6 more
Journal ArticleDOI
Abstract 1124: PTEN loss confers resistance to anti-PD-1 therapy in NSCLC by increasing tumor infiltration of T regulatory cells
Francisco Exposito,Miriam Redrado,Maeva Houry,Katherine Hastings,Magdalena Molero-Abraham,Teresa Lozano,Jose Luis Solorzano,Julián Sanz Ortega,Ramon Amat,Esther Redin,Sergio Valderrama de León,Javier Garcia Garcia,Diego Serrano,Karmele Valencia,Camila Robles-Oteiza,Giorgia Foggetti,Enriqueta Felip,Juan José Lasarte,Luis Paz-Ares,Jon Zugazagoitia,Katerina Politi,Luis M. Montuenga,Alfonso Calvo +22 more
TL;DR: Exposito et al. as discussed by the authors showed that PTEN loss led to a deregulation of multiple pathways related to immunosuppression, with a positive enrichment in IL-6/JAK/STAT3 and TNF-α via NFkB.
Posted ContentDOI
Circulating Proteome for Pulmonary Nodule Malignancy
Elham Khodayari Moez,Yonathan Brhane,M Warkentin,Sandra Lam,Jk Field,Luis M. Montuenga,Javier J. Zulueta,Karmele Valencia,Miguel Mesa-Guzman,S. Atkar-Khattra,Michael P.A. Davies,Brooke S. Grant,A. Pasquier Nialet,Christopher I. Amos,Hilary A. Robbins,Mattias Johansson,Rayjean J. Hung +16 more
TL;DR: Circulating protein markers can help to differentiate between malignant and benign pulmonary nodules in lung cancer screening programs, and can increase sensitivity to 0.80 for nodule malignancy compared to the Brock model.
sputum from patients with lung cancer
Ruben Pio,Javier Santos García,Leticia Corrales,Daniel Ajona,Michael Fleischhacker,Felipe Cardenal,Luis Seijo,Javier J. Zulueta,Ernest Nadal,María Dolores Lozano,Bernd Schmidt,Luis M. Montuenga,Christian Witt +12 more
TL;DR: The use of molecular biomarkers may enhance the sensitivity of cytologic examination in the detection of lung cancer in patients and patients with non-malignant respiratory diseases.
Progression for Lung Cancer Anaphylatoxin C5a Creates a Favorable
María J. Pajares,Luis M. Montuenga,Ruben Pio Lasarte,Jose I Riezu-Boj,John D. Lambris,Ana Rouzaut,Leticia Corrales,Daniel Ajona,Stavros Rafail,José Miguel Juan +9 more
TL;DR: Maria J. Pajares, Luis M. Montuenga and Ruben PioLasarte, Jose I. Riezu-Boj, John D. Lambris, Ana Rouzaut, Leticia Corrales, Daniel Ajona, Stavros Rafail, Juan J.